Crossmark

Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia

Crossref DOI link: https://doi.org/10.1186/s12916-018-1229-x

Published Online: 2018-12-17

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Desalegn, Hailemichael

Aberra, Hanna

Berhe, Nega

Mekasha, Bitsatab

Stene-Johansen, Kathrine

Krarup, Henrik

Pereira, Andre Puntervold

Gundersen, Svein Gunnar

Johannessen, Asgeir http://orcid.org/0000-0001-5966-7166
Funding

Funding for this research was provided by:

Norges Forskningsråd (220622/H10)

Helse Sør-Øst RHF (2011068)
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 23 May 2018

Accepted: 30 November 2018

First Online: 17 December 2018

Ethics, consent and permissions

: The study was approved by the Regional Committee for Medical and Health Research Ethics in Norway and the National Research Ethics Review Committee in Ethiopia, as well as the pertinent institutional ethical review boards. Written informed consent was obtained from all study participants.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.